The early-stage start-up has developed a mobile app that uses deep learning to deliver clinically safe and accurate predictions of blood glucose levels. This provides actionable metabolic care for individuals to reduce unhealthy glucose fluctuations, which is an immediate danger for over 400 million diabetics and a long-term threat for pre- and non-diabetics. OneTwenty's innovative solution revolutionizes the lives of diabetics and anyone else looking to improve their quality of life.